Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
FASEB J ; 35(7): e21701, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34143529

RESUMEN

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease. Although visceral hypersensitivity (VH) and disturbed gastrointestinal motility are typical pathophysiological features of IBS, the pathological mechanisms underlying this disease remain unclear. Serotonin system abnormalities are considered to play an important role in the pathomechanisms of IBS. Here, we hypothesize that similar alterations, including VH and colonic motility, induced by serotonin transporter (SERT) knockout result from altered serotonin signaling. We sought to determine the molecular mechanism underlying VH and colonic dysmotility induced by SERT knockout. We found that female SERT (slc6a4)-knockout (KO; ie, slc6a4-/- ) rats exhibited lower pain pressure thresholds (PPTs) than wild-type (WT; ie, slc6a4+/+ ) rats in response to colorectal distension (CRD). Significantly increased fecal pellet output and reduced concentration of serum tryptophan were observed in the female SERT KO rats. The concentrations of 5-hydroxytryptamine (5-HT) in platelet-rich plasma (PRP) and serum in SERT KO rats were lower than those in WT rats, but the numbers of enterochromaffin cells (ECs) and the concentrations of 5-HT in colon of SERT KO rats were higher than those of WT rats. Finally, increased expression levels of 5-HT1B receptors, 5-HT2C receptors, 5-HT3A receptors, 5-HT3B receptors, 5-HT6 receptors, 5-HT7 receptors, and glycosylated dopamine transporters (DATs) were found in the female SERT KO rats. We concluded that alterations in the serotonin system induced by the knockout of slc6a4 might result in VH and accelerated gastrointestinal motility in female SERT KO rats, which can be used as an animal model of IBS.


Asunto(s)
Colon/patología , Motilidad Gastrointestinal , Hipersensibilidad/patología , Síndrome del Colon Irritable/patología , Proteínas de Transporte de Serotonina en la Membrana Plasmática/fisiología , Serotonina/metabolismo , Animales , Animales Modificados Genéticamente , Colon/metabolismo , Modelos Animales de Enfermedad , Femenino , Hipersensibilidad/etiología , Hipersensibilidad/metabolismo , Síndrome del Colon Irritable/etiología , Síndrome del Colon Irritable/metabolismo , Ratas , Ratas Sprague-Dawley
2.
Oncol Lett ; 20(2): 1922-1930, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32724436

RESUMEN

Efficacy of abiraterone combined with flutamide on patients with prostate cancer (PCa) and its effect on levels of miR-493-5p and miR-195-5p contained in serum were investigated. The medical records of 146 PCa patients admitted to Longhua Hospital Shanghai University of Traditional Chinese Medicine from January 2011 to December 2013 were selected. Eighty-four patients were treated with abiraterone combined with flutamide as a study group, 62 patients were treated with abiraterone alone as a control group. The curative effect, adverse reactions, quality of life and five-year overall survival (OS) of the two groups were compared. The serum prostate-specific antigen (PSA) level was measured by radioimmunoassay at 3 days (T1) before treatment, 1 month (T2), 2 months (T3), and 6 months (T4) after treatment, and the relative expression of miR-493-5p and miR-195-5p in serum were detected by qRT-PCR. The total effective rate of the study group was significantly higher than that of the control group (P<0.05). The total incidence of toxic and side effects in the study group was significantly lower than that in the control group (P<0.05). The improvement rate of quality of life in the study group was significantly higher than that in the control group (P<0.05). OS in the study group was significantly higher than that in the control group at 5 years (P<0.05). There was no significant difference in serum PSA level between the two groups at T1 (P>0.05); there was no significant difference in the relative expression of miR-493-5p and miR-195-5p between the two groups at T1 (P>0.05). In conclusion, abiraterone combined with flutamide has better curative effect and lower incidence of adverse reactions in patients with metastatic castration-resistant PCa (CRPC) than abiraterone alone, and can increase the expression levels of miR-493-5p and miR-195-5p in patient serum.

3.
Polymers (Basel) ; 9(10)2017 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-30965813

RESUMEN

Polyaniline nanotubes were successfully synthesized by a facile in situ chemical oxidative polymerization method using urea as soft template. When the urea/aniline molar ratio is 3:1, the as-prepared nanotubular polyaniline (PANI-3) shows regular and uniform square capillaries, which provides a high electrode/electrolyte contact, easy ion diffusion and enhanced electroactive regions during the electrochemical process, leading to weak internal resistance and improved electrochemical performance. The PANI-3 sample exhibits a high specific capacitance of 405 F/g at current density of 0.2 A/g, and PANI only has a specific capacitance of 263 F/g. At current density of 1 A/g, the capacitance of PANI-3 is still 263 F/g (64.9% of the capacitance at 0.2 A/g). Such a PANI-3 nanotube, with regular and uniform capillary, is a promising electrode material for high-performance supercapacitors.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA